Profile data is unavailable for this security.
About the company
Fleury SA is a Brazil-based company engaged in the provision of medical laboratory services. The Company’s activities are divided into three business lines: Patient Service Centers (PSC), B2B and Dental Diagnosis. The PCS division offers private medical diagnostics. The B2B division is responsible for clinical analysis and diagnostic imaging in partner hospitals, as well as tests for laboratories, hospitals and clinics throughout Brazil. The Dental Diagnosis division provides dental diagnostic imaging through Papaiz Associados Diagnosticos por Imagem SA, a joint venture with Odontoprev SA. The Company operates through several brands, such as Fleury Medicina e Saude, Clinica Felippe Mattoso e Weinmann, a+ Medicina Diagnostica, Diagnoson a+, Diagmax and Inlab, among others.
- Revenue in BRL (TTM)7.14bn
- Net income in BRL497.86m
- Incorporated1964
- Employees27.30k
- LocationFleury SAAv. General Valdomiro de Lima508, JabaquaraSAO PAULO 04.344-070BrazilBRA
- Phone+55 1 150351986
- Fax+55 1 150147425
- Websitehttps://www.fleury.com.br/
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 06 Jun 2024 | 11.91m | 2.18% |
| APG Asset Management NVas of 31 Dec 2022 | 7.31m | 1.34% |
| Bram Bradesco Asset Management S/A DTVMas of 29 Feb 2024 | 6.93m | 1.27% |
| Goldman Sachs Asset Management LPas of 29 Mar 2024 | 6.60m | 1.21% |
| Kapitalo Investimentos Ltda.as of 29 Feb 2024 | 6.51m | 1.19% |
| BlackRock Fund Advisorsas of 06 Jun 2024 | 4.85m | 0.89% |
| Handelsbanken Fonder ABas of 31 May 2024 | 3.88m | 0.71% |
| BlackRock Brasil Gestora de Investimentos Ltda.as of 06 Jun 2024 | 3.86m | 0.71% |
| Lemanik Asset Management SAas of 30 Jun 2023 | 3.66m | 0.67% |
| Funda��o dos Economi�rios Federais FUNCEFas of 29 Feb 2024 | 3.55m | 0.65% |
